• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Infectious Disease

Antibody testing may provide diagnostic support for SARS-CoV-2 infection

byHarsh ShahandDeepti Shroff Karhade
July 15, 2020
in Infectious Disease, Public Health, Pulmonology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Antibody testing to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was shown to provide diagnostic support for patients who tested negative by nucleic acid amplification test (NAAT) but remained clinically suspicious for the infection.

2. Antibody testing to SARS-CoV-2 was shown to contribute to the existing infection serology diagnosis.

Evidence Rating Level: 3 (Average)

Study Rundown: The gold standard for COVID-19 diagnosis is nucleic acid amplification test (NAAT), although there are limitations to the test arising from intermittent viral shedding and nasopharyngeal swab techniques. Serologic testing for COVID-19 is used throughout public health for patient diagnostics and can serve as a complementary test to NAAT. However, the clinical applications of serologic testing for COVID-19 are undefined. As such, this study determined the SARS-CoV-2 spike protein serum assay’s ability to present antibody kinetics and subsequent clinical use. Results from antibody testing were able to provide diagnostic patient support when patients had tested negative through NAAT but remained at clinical suspicion for COVID-19. This case-control study was limited by its sampling of hospitalized patients. The convenience sampling in the study created a bias since patients who were asymptomatic carriers were not included in the antibody testing. Therefore, the findings of this study may not be generalized to the public. Nonetheless, this study was strengthened by showing the complementary benefit of antibody testing with NAAT for SARS-CoV-2.

Click to read the study in Annals of Internal Medicine

Relevant Reading: Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma

In-Depth [case-control study]: This case-control study included 628 participants from a single medical center. Participants were included if they had nasopharyngeal swab testing conducted between March 11, 2020, and April 12, 2020, testing conducted at Johns Hopkins University Medical Center, and NAAT testing conducted from nasopharyngeal swab samples. Participants with an absence of NAAT testing of nasopharyngeal swab samples were excluded. Based on these criteria, the cohort consisted of 11,066 tests within which, two groups were formed. The case group consisted of 115 hospitalized patients and the control group consisted of 513 participants. All of these participants underwent serum antibody testing for the presence of IgG and IgA antibodies against the S1 domain of the SARS-CoV-2 spike protein. The serum IgG antibodies against SARS-CoV-2 were significantly higher in the case group (median, 2.01 units, interquartile range [IQR], 0.16 to 44.33 units) compared to the control group (median, 0.10 units, IQR, 0.05 to 0.19 units; P < 0.001). Furthermore, serum IgG measurement at least 14 days after symptom onset distinguished case patients from the control group with a sensitivity of 0.976 (95% confidence interval [CI], 0.928 to 0.995) and specificity of 0.988 (95% CI, 0.974 to 0.995). Serum IgA measurement within the same time frame had a similar sensitivity (0.984, 95% CI, 0.939 to 0.999) and lower specificity (0.880, 95% CI, 0.851 to 0.905). Finally, in patients who tested negative with NAAT but had high clinical suspicion of COVID-19 infection, serum antibodies for SARS were present in a subset of the case patients tested (5 out of 6, 83%), while antibodies were not present in the control group (0 out of 12, 0%). Taken together, the antibody testing for SARS-CoV-2 may provide diagnostic support for patients who have negative NAAT results but still have a high clinical suspicion of the infection.

RELATED REPORTS

SAR-CoV-2 infection during pregnancy may lead to adverse neurodevelopmental outcomes in male offspring

Past infection with pre-omicron variants of COVID-19 protects against re-infection

Symptom and viral relapse more common in COVID-19 patients without antiviral treatment

Image: PD

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: antibody testingCoronavirusIgAIgGnucleic acid amplification test (NAAT)SARS-CoV-2
Previous Post

Intestinal virome signature associated with severity of nonalcoholic fatty liver disease

Next Post

Association of rapid eye movement sleep with mortality in middle-aged and older adults

RelatedReports

Paternal factors associated with short interpregnancy interval
Infectious Disease

SAR-CoV-2 infection during pregnancy may lead to adverse neurodevelopmental outcomes in male offspring

March 29, 2023
Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children
Chronic Disease

Past infection with pre-omicron variants of COVID-19 protects against re-infection

March 28, 2023
Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children
Chronic Disease

Symptom and viral relapse more common in COVID-19 patients without antiviral treatment

March 21, 2023
Emergency

Different variants presenting with different presentations amongst children with COVID-19 infections

March 13, 2023
Next Post

Association of rapid eye movement sleep with mortality in middle-aged and older adults

Association of rapid eye movement sleep with mortality in middle-aged and older adults

Association of rapid eye movement sleep with mortality in middle-aged and older adults

Rapid time to revascularization after ischemic stroke associated with improved functional outcomes

Ticagrelor and aspirin taken post stroke may decrease the risk of recurrent stroke

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Exhaled volatile organic compounds predict bronchopulmonary dysplasia in preterm infants
  • Wellness Check: Mental Health
  • SAR-CoV-2 infection during pregnancy may lead to adverse neurodevelopmental outcomes in male offspring
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options